PHARMANOVA AS
Organization
- CEO
- IL
- Chairman of the board
- Years since formation
- 12 years
- since Jan 22, 2013
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,000
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2024
- 18,457,179
- NOK
- Annual total result 2024
- 1,267,041
- NOK
- Total equity 2024
- 3,179,874
- NOK
Last update: Sep 9, 2025
Management
Management / administration
Name | Role | Shares |
---|---|---|
IL | Managing Director/CEO | - |
Board
Name | Role | Shares |
---|---|---|
Chairman | 11.98 % indirectly |
Others
Name | Role | Shares |
---|---|---|
Accountant | - | |
Auditor | - |
Top 10 individual shareholders
Name | Role | Shares |
---|---|---|
RA | - | 44.26 % indirectly |
HR 1960 | - | 12.87 % indirectly |
Chairman | 11.98 % indirectly | |
TB | - | 5.15 % indirectly |
SL 1984 | - | 3.09 % indirectly |
SL 1988 | - | 3.09 % indirectly |
TA | - | 1.95 % indirectly |
OL | - | 1.54 % indirectly |
LS | - | 1.52 % indirectly |
- | 1.52 % indirectly |
Last update: Oct 26, 2024
Ownership
Company shareholders
Name | Share class | Total number of shares | Share |
---|---|---|---|
Ordinary shares | 1,000 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 8,687,729Operating profit 2024: NOK -2,921,338Employees: 5
Financials
in NOK
Summary
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 18,457,179 | 5,832,539 | 2,588,736 | 3,684,391 |
Annual Total Result | 1,267,041 | 222,148 | -109,634 | -476,671 |
Total assets | 10,329,273 | 8,156,022 | 2,298,306 | 2,293,177 |
Total liabilities | 7,149,399 | 6,243,189 | 607,622 | 492,858 |
Total equity | 3,179,874 | 1,912,833 | 1,690,685 | 1,800,319 |
P&L
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 18,457,179 | 5,832,539 | 2,588,736 | 3,684,391 |
Total operating costs | 17,116,101 | 5,673,672 | 2,736,242 | 4,144,129 |
Operating result | 1,341,078 | 158,866 | -147,506 | -459,738 |
Financial income/costs | 183,359 | 63,282 | 35,641 | -15,531 |
Profit before tax | 1,524,437 | 222,148 | -111,865 | -475,269 |
Total tax & extraordinary income/cost | 257,396 | 0 | -2,231 | 1,402 |
Annual Total Result | 1,267,041 | 222,148 | -109,634 | -476,671 |
Balance overview
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total fixed assets | 25,000 | 41,000 | 160,000 | 0 |
Total current assets | 10,304,273 | 8,115,022 | 2,138,306 | 2,293,177 |
Total assets | 10,329,273 | 8,156,022 | 2,298,306 | 2,293,177 |
Short term debt | 6,892,003 | 6,243,189 | 607,622 | 490,627 |
Long term debt | 257,396 | 0 | 0 | 2,231 |
Total liabilities | 7,149,399 | 6,243,189 | 607,622 | 492,858 |
Contributed capital | 100,000 | 100,000 | 100,000 | 100,000 |
Retained earnings | 3,079,874 | 1,812,833 | 1,590,685 | 1,700,319 |
Total equity | 3,179,874 | 1,912,833 | 1,690,685 | 1,800,319 |
Total equity and liabilities | 10,329,273 | 8,156,022 | 2,298,306 | 2,293,177 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises